- Home
- BEDU vs ANVS Comparison
BEDU vs ANVS Comparison
Compare BEDU & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- ANVS
- Stock Information
- Founded
- BEDU 1994
- ANVS 2008
- Country
- BEDU United Kingdom
- ANVS United States
- Employees
- BEDU N/A
- ANVS 6
- Industry
- BEDU Other Consumer Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- ANVS Health Care
- Exchange
- BEDU Nasdaq
- ANVS Nasdaq
- Market Cap
- BEDU 54.0M
- ANVS 55.5M
- IPO Year
- BEDU 2017
- ANVS 2020
- Fundamental
- Price
- BEDU $1.85
- ANVS $2.89
- Analyst Decision
- BEDU
- ANVS Strong Buy
- Analyst Count
- BEDU 0
- ANVS 4
- Target Price
- BEDU N/A
- ANVS $18.00
- AVG Volume (30 Days)
- BEDU 2.3K
- ANVS 344.4K
- Earning Date
- BEDU 08-01-2025
- ANVS 08-14-2025
- Dividend Yield
- BEDU N/A
- ANVS N/A
- EPS Growth
- BEDU N/A
- ANVS N/A
- EPS
- BEDU N/A
- ANVS N/A
- Revenue
- BEDU $224,321,752.00
- ANVS N/A
- Revenue This Year
- BEDU N/A
- ANVS N/A
- Revenue Next Year
- BEDU N/A
- ANVS N/A
- P/E Ratio
- BEDU N/A
- ANVS N/A
- Revenue Growth
- BEDU N/A
- ANVS N/A
- 52 Week Low
- BEDU $1.35
- ANVS $1.11
- 52 Week High
- BEDU $2.41
- ANVS $11.29
- Technical
- Relative Strength Index (RSI)
- BEDU 58.50
- ANVS 58.30
- Support Level
- BEDU $1.76
- ANVS $2.63
- Resistance Level
- BEDU $1.91
- ANVS $2.89
- Average True Range (ATR)
- BEDU 0.05
- ANVS 0.23
- MACD
- BEDU 0.01
- ANVS 0.01
- Stochastic Oscillator
- BEDU 63.89
- ANVS 83.08
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.